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ABSTRACT
An RNA-dependent RNA polymerase (RdRp) is the
central catalytic subunit of the RNA-synthesizing
machinery of all positive-strand RNA viruses.
Usually, RdRp domains are readily identifiable by
comparative sequence analysis, but biochemical
confirmation and characterization can be ham-
pered by intrinsic protein properties and technical
complications. It is presumed that replication and
transcription of the 30-kb severe acute respiratory
syndrome (SARS) coronavirus (SARS-CoV) RNA
genome are catalyzed by an RdRp domain in the
C-terminal part of nonstructural protein 12 (nsp12),
one of 16 replicase subunits. However, thus far
full-length nsp12 has proven refractory to expres-
sion in bacterial systems, which has hindered both
the biochemical characterization of coronavirus
RNA synthesis and RdRp-targeted antiviral drug
design. Here, we describe a combined strategy
involving bacterial expression of an nsp12 fusion
protein and its in vivo cleavage to generate and
purify stable SARS-CoV nsp12 (106 kDa) with a
natural N-terminus and C-terminal hexahistidine
tag. This recombinant protein possesses robust
in vitro RdRp activity, as well as a significant DNA-
dependent activity that may facilitate future inhibitor
studies. The SARS-CoV nsp12 is primer dependent
on both homo- and heteropolymeric templates,
supporting the likeliness of a close enzymatic col-
laboration with the intriguing RNA primase activity
that was recently proposed for coronavirus nsp8.
INTRODUCTION
The central enzymatic activity in the life cycle of
positive-strand RNA (+RNA) viruses is the process of
RNA-templated RNA synthesis. In mammalian cells, the
replication of +RNA genomes always occurs in the cyto-
plasm where the viral RNA-synthesizing machinery is
commonly associated with (modified) cytoplasmic
membranes, which presumably provide physical support
and may serve to protect the complex from host defense
mechanisms (1,2). The viral enzyme complex contains an
RNA-dependent RNA polymerase (RdRp) as its core
catalytic subunit for the production of negative strand
RNA (–RNA), new genome molecules and in many
virus groups also subgenomic (sg) messenger RNAs
(mRNAs) (1,3).
Coronaviruses (CoVs) are a family of +RNA viruses
that infect a wide range of vertebrates including humans,
as exemplified by severe acute respiratory syndrome
(SARS) and various respiratory infections caused by
less-virulent family members (4). The group is also
known for its exceptionally large polycistronic genome
of 30 kb, which is 50 capped and 30 polyadenylated
RNA. The 50-proximal two-thirds of the CoV genome
(open reading frames 1a and 1b) are translated into
the viral replicase polyproteins pp1a and pp1ab. The
30-proximal third encodes the viral structural proteins
and several so-called accessory proteins, which can only
be expressed following the production of a set of four to
nine sg mRNAs (5,6). In particular, it is this CoV
hallmark that has attracted attention over the years,
since these sg mRNAs consist of sequences that are
noncontiguous in the viral genome: a common 50 leader
sequence is attached to body segments representing a
variable part of the 30-proximal genomic region.
According to the now widely supported transcription
model of Sawicki and Sawicki (7), the arterivirus and
CoV sg RNAs derive from a discontinuous step during
minus-strand RNA synthesis that is guided by specific
RNA signals and resembles copy-choice RNA recombina-
tion (5,6,8). This mechanism produces a set of subgenome-
length negative-strand templates from which the sg
mRNAs are produced. The unusual genome size of
CoVs and the complexity of their RNA synthesis hint at
*To whom correspondence should be addressed. Tel: +31 71 5261657; Fax: +31 71 5266761; Email: e.j.snijder@lumc.nl
 doi:10.1093/nar/gkp904
deoxy-nucleotides on a DNA template. This work there-
fore provides a solid basis for the further biochemical
characterization of the coronavirus nsp12 and the
detailed dissection of its role in viral replication and tran-
scription. Understanding the enzyme’s properties will be
essential for the development of selective coronavirus
RdRp inhibitors and will likely provide novel insights
into the intriguing (evolutionary) relation between the
RdRp of nidoviruses and other groups of +RNA viruses.
MATERIALS AND METHODS
Cloning and expression of recombinant SARS-CoV nsp12
The amino acid sequence of SARS-CoV nsp12, residues
S4370 to Q5301 of replicase pp1ab, is fully conserved
among all sequenced SARS-CoV isolates. For our study,
the nsp12-coding region was amplified by reverse
transcription-polymerase chain reaction (RT-PCR) from
the genome of SARS-CoV Frankfurt-1 (AY291315).
During amplification, the ORF1a/1b 1 ribosomal frame-
shift near the 50-end of the gene was corrected in a
translationally silent manner. Primers used for amplifica-
tion were SAV424 50-GCGGGTACCCCGCGGTGGAT
CTGCGGATGCATCAA-30 and SAV425 50-GCGCGAT
CGGGATCCCTGCAAGACTGTATGT-30, correspond-
ing to SARS-CoV genome positions 13 327–13 387 and
16 152–16 166, respectively. The PCR amplicon was
digested with SacII and BamHI, and ligated into expres-
sion vector pET26-Ub-CHis6 (26). Following confirma-
tion of the nucleotide sequence of the amplicon and
using the flanking XbaI and XhoI restriction sites, the
ubiquitin-nsp12-His6 fusion gene (Ub-nsp12-CHis6) was
subcloned into vector pASK3 (IBA) and thereby placed
under the control of a tetracycline-inducible promoter.
This ruled out the known risk of potential contamination
with T7 RNA polymerase, as it can occur when using a T7
promoter to drive expression of other RdRps in bacterial
expression systems. Nsp12 active-site mutant D618A,
carrying an Asp618Ala substitution, was engineered via
site-directed mutagenesis according to the QuikChange
protocol (Stratagene), using primers SAV526 50-CCTTA
TGGGTTGGGCTTATCCAAAATGTG-30 and SAV527
50-CACATTTTGGATAAGCCCAACCCATAAGGA-30.
For nsp12 expression, the pASK3-Ub-nsp12-CHis6
plasmid was transformed to Escherichia coli C2523 cells
(New England Biolabs) together with the Ubp1 protease
expression plasmid pCGI (26), unless indicated otherwise
for particular experiments. Routinely, 250ml of Luria
Broth, containing ampicillin (50 mg/ml) and chloram-
phenicol (34mg/ml), was inoculated 1:1000 with 3ml o/n
precultures and cells were grown at 37C to OD600 >0.7.
Subsequently, the cells were slowly cooled to room tem-
perature, tetracycline was added to a final concentration
of 200 mg/ml and the cells were further grown at 20C for
another 16 h. Cells were harvested by centrifugation,
washed once with ice-cold phosphate-buffered saline
(PBS) and stored at 20C until protein purification.
SARS-CoV nsp12 expression vectors pKM596-nsp12
(kindly provided by Dr. Isabelle Imbert and Dr. Bruno
Canard) and pET102-Thio-nsp12 (a kind gift of
an RdRp that may have special properties, either by itself 
or in conjunction with other subunits of the CoV replica-
tion/transcription complex (RTC).
CoV replication and transcription are driven by the 15 
or 16 viral nonstructural proteins (nsps) encoded in the 
replicase gene, which include many enzyme activities that 
are rare or lacking in other families of +RNA viruses 
(9,10). These nsps are produced during co- and post-
translational processing of the pp1a and pp1ab replicase 
polyproteins by two or three internal viral proteinases 
(11). In the years following the 2003 SARS outbreak, 
bioinformatics, structural biology, (reverse) genetics and 
biochemical studies have all contributed to the in-depth 
characterization of CoV nsps in general and those of 
SARS-CoV in particular (9,10,12). Currently documented 
enzyme activities include proteinases (11), a putative RNA 
primase (13), a superfamily 1 helicase (14), an exo- and an 
endoribonuclease (15,16), single-stranded RNA (ssRNA)-
binding proteins (17,18) and two methyltransferases 
(19,20). Following the sequence analysis of the first CoV 
genomes, more than two decades ago, the putative RdRp 
domain of the coronavirus RTC had already been 
identified by comparative sequence analysis (21,22). The 
C-terminal, two-thirds of the 932-amino-acid subunit, 
now known as nsp12 was confidently aligned with the 
conserved motifs of well-known RdRps (22,23). In view 
of its unprecedented size among viral RdRp subunits, 
which commonly consist of 500–600 amino acids, nsp12 
may well harbor other functional domains in its as-yet 
uncharacterized N-terminal domain. Biochemical infor-
mation on the CoV RdRp has, however, remained 
scarce thus far, particularly since full-length nsp12 was 
refractory to expression in bacterial systems. Preliminary 
evidence for the in vitro RdRp activity of nsp12 came from 
a study of the SARS-CoV enzyme by Cheng et al. (24). 
However, their experiments, employing a glutathione 
S-transferase (GST)-nsp12 fusion protein, were ham-
pered by protein instability, which resulted in the fragmen-
tation of the protein into three parts. Primer-dependent 
activity on poly(A) templates was observed in filter 
binding assays, but the enzyme biochemistry was not 
further characterized in detail.
Given its pivotal role in viral replication and the efficacy 
of polymerase inhibitors used to combat other virus 
infections, the SARS-CoV RdRp is widely regarded as 
an important and attractive target for the rational 
design of anti-CoV drugs (23,25). We therefore sought 
to solve the technical issues described above and develop 
reliable protocols for stable expression, purification and 
in vitro activity of the full-length CoV nsp12. In this 
article, we describe an expression strategy utilizing in 
vivo cleavage in a bacterial expression system by ubiquitin 
carboxyl-terminal hydrolase 1 (Ubp1), which releases the 
small N-terminal fusion partner ubiquitin (Ub) and 
generates a recombinant nsp12 protein containing its 
natural N-terminus. This was found to be a critical step 
on the road toward purification of a stable recombinant 
SARS-CoV RdRp. We subsequently established that full-
length nsp12 can readily synthesize RNA in a primer-
dependent fashion on both homo- and heteropolymeric 
RNA templates and is also efficient at incorporating
Dr. Susanne Pfefferle and Dr. Christian Drosten) were
used to transform E. coli BL21(DE3) cells and expression
was performed using the auto-induction medium
ZYM-5052 (27).
Purification of SARS-CoV nsp12-His
Cell pellets were thawed on ice, resuspended in binding
buffer (20mM HEPES pH 7.4, 500mM NaCl, 20mM
imidazole, 10% glycerol, 0.05% Tween-20 and 5mM
b-mercaptoethanol) and lysed by sonication. Cell debris
was removed by ultra-centrifugation at 20 000 g and the
cleared supernatant was incubated with Talon beads
(Clontech) for 2 h at 4C. The beads were washed three
times with 20 vol of binding buffer, loaded onto spin
columns and finally the His-tagged protein was eluted
with 300mM imidazole in binding buffer. The eluate
was analyzed by sodium dodecyl sulfate polyacrylamide
gel electrophoresis (SDS–PAGE) and typically found
to be 80–85% pure. Subsequently, gel filtration on
a Superdex 200 column (GE Healthcare) in 20mM
HEPES, 500mM NaCl, 5% glycerol, 5mM b-mercapto-
ethanol and 0.1% Tween-20 was used to improve purity
to 95%. To estimate the molecular mass of nsp12, a
standard curve for hydrodynamic elution was made
using chymotrypsinagen A, conalbumin, aldolase and
dextran blue (all purchased from GE Healthcare) as size
markers and fitted to a linear equation (R2=0.99).
After the gel filtration step, the nsp12-containing frac-
tions were pooled, concentrated with Ultrafree 10-kDa
filter columns (Millipore) and dialyzed overnight against
1000 sample volumes of dialysis buffer (20mM HEPES
pH 7.4, 100mM NaCl, 0.1% Triton-X 100, 1mM DTT
and 50% glycerol) in cellulose tubing (SnakeSkin, Pierce).
Protein concentrations were determined using a Bradford
assay and a bovine serum albumin (BSA) standard curve,
and the purified protein was stored at 20C. When using
expression vectors pKM596-nsp12 and pET102-Thio-
nsp12, protein purification procedures were essentially
similar to those described above, except that amylose
resin (New England Biolabs) was used to bind the
pMK596-nsp12 product, which was eluted using a buffer
containing 10mM amylose instead of imidazole.
SDS–PAGE and western blotting
Cells were lysed in Laemmli’s sample buffer (28),
separated on 8% SDS–PAGE gels and either electro-
blotted to polyvinylidene fluoride (PVDF) membrane
(GE Healthcare) or stained directly with Coomassie
G-250 according to standard protocols. Prior to incuba-
tion with a SARS-CoV nsp12-specific rabbit antiserum (a
kind gift from Dr. Mark Denison) (29), blot membranes
were blocked with 10% skimmed milk and 0.02% Tween-
20 in PBS. Blots were washed with 0.02% Tween-20
in PBS, incubated with a swine-anti-rabbit horseradish
peroxidase conjugate diluted in 5% skimmed milk,
0.02% Tween-20 and PBS, washed and subjected to
ECL Plus chemiluminescence detection (GE Healthcare).
Preparation of templates
RNA oligonucleotides and their DNA counterparts
SAV557R 50 -GCUAUGUGAGAUUAAGUUAU-30
and SAV481R 50-UUUUUUUUUUAUAACUUAAUC
UCACAUAGC-30, SAV555R 50- UUUUUUUUUUU
UUUUUUUUUAUAACUUAAUCUCACAUAGC-30
and SAV556R 50-UCUCUCUCUCUCUCUCUCUCAU
AACUUAAUCUCACAUAGC-30 were purchased from
Eurogentec, excised as a single band from 7M urea/15%
polyacrylamide gels, eluted overnight in deionized water
and desalted using NAP-10 columns (GE Healthcare).
To anneal RNA duplexes, oligonucleotide mixtures in
annealing buffer [20mM Tris–HCl pH 8.0, 50mM NaCl
and 5mM ethylenediaminetetraacetic acid (EDTA)] were
heat denatured, slowly cooled to room temperature and
subsequently purified from 15% nondenaturing poly-
acrylamide gels.
RdRp activity assays
To test the in vitro RdRp activity of SARS-CoV nsp12-
CHis6, 0.1 mM of the protein (unless otherwise indicated)
was incubated at 30C in the presence of 1 mM template,
0.17mM [a-32P]ATP (0.5 mCi/ml; Perkin-Elmer), 50 mM
ATP (Roche), 20mM Tris–HCl (pH 8.0), 10mM
NaCl, 10mM KCl, 6mM MgCl2, 5% glycerol, 0.01%
Triton-X 100, 1mM DTT and 0.5U of RNaseOUT
(Invitrogen). Glycerol and NaCl were introduced with
the addition of enzyme due to their presence in the
nsp12 storage buffer. RdRp reactions were terminated
by adding an equal volume of 90% formamide, 50mM
EDTA pH 8.0, 0.01% bromophenol blue and xylene
cyanol. Reaction products were analyzed on 7M Urea,
20% polyacrylamide gels buffered with 1 TBE (90mM
Tris, 90mM H3BO3 and 2mM EDTA). Gels were run
for 5 h at 2000V and analyzed using phosphorimaging.
Plates were scanned on a Typhoon variable mode
scanner (GE Healthcare) and products were quantified
with ImageQuant TL 7.0 (GE Healthcare). To calculate
the amount of [a-32P]AMP incorporated from the
phosphorimager signal, a 102–105 dilution series of
the [a-32P]ATP stock was spotted in triplicate on
Whatman filter and exposed alongside the PAGE gel of
interest. Using the standard curve, phosphorimager
counts were converted into the amount of label incorpo-
ration and kinetic traces were fit to a linear function
with the MATLAB 2008b Curve Fitting Toolbox
(Mathworks).
Electrophoretic mobility shift assays
A dilution series of SARS-CoV RdRp in storage buffer
was incubated for 10min at room temperature with
0.2 nM of 32P-labeled oligonucleotide SAV557R (see
above), in the presence or absence of the complementary
oligonucleotide SAV481R. Samples were then directly
loaded on to 8% acrylamide gels containing 5% glycerol
and 0.5 TBE and were run at 100V for 2 h at 4C. Gels
were dried on Whatman filter paper and bands were
quantified by phosphorimaging. Using the MATLAB
2008b Curve Fitting Toolbox, the percentage of RNA
expression of the full-length Ub-tagged nsp12-CHis6 was
compared to that of variants containing either maltose
binding protein (MBP) or thioredoxin (Thio) as fusion
partner. As shown in Figure 1B and as also documented
in the previous work of Cheng et al. (24), expression
and purification of nsp12 fusion proteins resulted in
the abundant and progressive fragmentation of the
protein. Based on their sizes in SDS–PAGE, the
cleavage products likely were the 64- and 39-kDa nsp12
degradation products as found by Cheng et al. (24)
when working with their GST-nsp12 fusion construct
(Figure 1B). Therefore, our results confirmed and
extended the previously reported observations regarding
the instability of SARS-CoV nsp12 when expressed in
E. coli as part of a fusion protein.
In studies with the poliovirus (PV) RdRp (3Dpol), it was
previously shown that N-terminal foreign sequences, even
the addition of a single methionine residue, can have a
significant impact on enzyme activity (26,30). Structural
studies subsequently revealed that a native N-terminus is
required for the proper folding of the RdRp’s ‘fingers’
subdomain and the positioning of the 3Dpol active
Figure 1. Expression and purification of the SARS-CoV nsp12. (A) Expression of nsp12 was performed in the presence of the ubiquitin (Ub)
protease Ubp1, which removed the N-terminal Ub fusion partner by cleaving after the LRGG signature that formed the junction between the Ub
and nsp12 moieties. This in vivo cleavage created the native nsp12 amino-terminus with the sequence SADAS. (B) Western blotting using an nsp12-
specific polyclonal antiserum identified a single band of the expected mass after purification of the in vivo cleaved expression product. Isolation of
fusion proteins with different N-terminal tags resulted in common patterns of degradation. Similar results were reported by Cheng et al. (24) for a
GST-nsp12 fusion protein. (C) Purified nsp12-CHis6 was readily visualized by Coomassie staining as a 106-kDa protein product, in line with the
expected mass. Inductions in the absence of Ubp1 expression, however, resulted in a mixture of full-length fusion protein and degradation products,
likely as a result of improper folding. No RdRp activity was observed for these preparations. (D) Gel filtration analysis of purified nsp12 in assay
buffer showed a single peak, corresponding to a globular molecular weight of 140±10kDa, suggesting that only the monomeric form of nsp12 is
present under the conditions used.
bound was fit to the Hill equation RNAbound = 
b*[nsp12]n/(Knd+ [nsp12]
n), where b is the upper binding 
limit, [nsp12] is the nsp12 concentration, n is the Hill coef-
ficient and Kd is the enzyme’s dissociation constant.
RESULTS
Stable expression and purification of full-length
SARS-CoV nsp12
A PCR amplicon encoding SARS-CoV nsp12 was first 
cloned into T7 expression vector pET26-Ub-CHis6, 
which provided the 932-aa viral protein with an 
N-terminal Ub tag (76 amino acids) and a C-terminal 
hexahistidine tag (Figure 1A). To avoid the known risk 
of T7 RNA polymerase contamination when purifying 
another RdRp using a T7 promoter-driven expression 
system [like E. coli BL21(DE3)], the Ub-nsp12-CHis6 
fusion gene was subsequently transferred to plasmid 
pASK3, placing it under control of a tetracycline-
inducible promoter. Initially, the protease that was later 
used to remove the Ub tag was not co-expressed and the
site (30). These findings suggested to us that N-terminal
additions might also hamper the proper folding of the
SARS-CoV RdRp and could thus be the principal cause
of its subsequent degradation. We therefore co-expressed
the C-terminal Ub protease Ubp1 (26), which specifically
recognizes the cleavage site in our fusion protein that
is located between the Ub moiety and the N-terminus of
nsp12 (LRGG#SADAS). Proteolytic cleavage of the
fusion protein at this site liberated an nsp12-CHis6
product (Figure 1A), now containing its natural N-
terminus. The expression of the Ubp1 protease was
driven by the relatively weak constitutive ADH1
promoter (26). Hence, to ensure optimal release of
nsp12-CHis6 by the protease, induction of Ub-nsp12-
CHis6 expression was performed only in the middle or
late log-phase of bacterial growth. Induction at lower
densities or on-column cleavages performed with the
cleavable MBP and Thio fusion proteins resulted in sig-
nificant amounts of degraded nsp12, which was inactive in
RdRp assays (data not shown).
As depicted in Figure 1B and C, the in vivo cleavage
product that we were able to routinely purify was of the
expected 106-kDa size (9) and was found to be stable, even
after multiple rounds of purification and prolonged
storage at 20C. Non-denaturing gel filtration yielded a
single peak corresponding to a size of about 140±10kDa
as estimated by comparison to a standard curve (Figure
1E–F). This is different from the calculated mass of
106 kDa, but may be explained by, e.g. a very open or
nonglobular structure of the protein. Moreover, unex-
pected behavior in gel filtration is not without precedent
for RdRps, as was, e.g. reported for the monomeric u6
RdRp P2 (31). Future structural studies involving electron
microscopy or crystallography will hopefully allow us to
address this question in more detail.
SARS-CoV nsp12 is a primer-dependent RdRp
+RNA virus replication may proceed through a variety
of scenarios, but essentially viral RdRps employ only two
fundamentally different mechanisms during the first step
of RNA synthesis: initiation can occur either de novo,
when the 30 hydroxyl group of the first nucleotide essen-
tially is the ‘primer’ to which a second nucleotide is added,
or initiation can depend on an oligonucleotide or protein
primer (32). Imbert et al. (13) recently showed that the
CoV nsp8 subunit, a relatively small protein (22 kDa)
that forms a hexadecameric complex with nsp7 (33), can
synthesize short oligonucleotides using poly(C) templates
or templates containing a 30 CCG/U motif. Although the
exact role of nsp8 remains to be studied in much more
detail, one of its proposed functions is that of an ‘RNA
primase’ (13). According to this hypothesis, and similar to
what has been documented for cellular DNA polymerases
(34), the oligonucleotide products of nsp8 activity would
serve as primers for the viral ‘main RdRp’, i.e. nsp12.
Some other observations were also consistent with the
possibility that the SARS-CoV main RdRp belongs to
the class of primer-dependent polymerases. First,
modeling of the structure of SARS-CoV nsp12 residues
400–900 suggested that the central domain of the protein
contains a G motif, a signature present in all primer-
dependent RdRps (23). Second, when using the unstable
GST-nsp12 fusion protein in combination with a poly(A)
template and a poly(U) primer, Cheng et al. (24) observed
a moderate RdRp activity in filter-binding assays.
Convincing evidence for the extension of an RNA
primer in vitro, however, has not been documented
thus far.
To qualitatively assess the polymerase activity of the
nsp12, we monitored the incorporation of nucleotides on
a well-defined synthetic RNA template, which was pre-
dicted to lack secondary structures that could affect the
enzyme’s processivity. This template (Figure 2A) consisted
of a 20-nt duplex and a 30 overhang of 10 uridylates, which
could serve as template during extension of the 20-mer
primer. As shown in Figure 2, primer extension was
revealed by both the incorporation of [a-32P]ATP
(Figure 2B) and the extension of the 32P-labeled primer
(Figure 2C). The use of single-stranded or homopolymeric
[poly(U) or poly(C)] templates did not lead to significant
incorporation of nucleotides (data not shown).
Based on sequence alignments of SARS-CoV nsp12
with RdRps of known structure, it was previously
concluded that the canonical aspartic acid residues
responsible for the coordination of the divalent cation in
the RdRp’s active site should be nsp12 residues 618, 760
Figure 2. SARS-CoV nsp12 primer extension assay and active-site
mutant. (A) Schematic showing the structure of the partially double-
stranded RNA template with 30 U10 stretch that served as template
for primer extension in the initial nsp12-based nucleotide incorporation
assay. (B) Comparison of the RdRp activity of wild-type nsp12 and
a D618A active-site mutant, which displayed minimal activity after
a 60-min incubation at 30C. (C) A primer extension assay using a 50
32P-labeled primer and ATP confirmed that wild-type nsp12, in contrast
to the D618A mutant, was able to elongate the 20-mer primer. The
slight reduction of input primer in the D618A lane probably resulted
from degradation by RNase activity. The D618A mutant showed
8±3% residual activity (mean of three independent experiments).
In the loading control (Figure 2B and C, lower panels) the two
nsp12 variants were visualized by silver staining of an SDS–PAGE gel.
6mM. Higher concentrations (20mM) ultimately abol-
ished activity (data not shown). The SARS-CoV RdRp
does not require Mn2+ for RNA synthesis, as previously
reported for the nsp9-RdRp of the arterivirus equine
arteritis virus (EAV), a distant relative in the order
Nidovirales (37). In fact, the presence of Mn2+ in an
RdRp assay utilizing a poly(U) template decreased the
fidelity of the SARS-CoV nsp12 relative to Mg2+ and
facilitated both transversional and transitional misincor-
porations (Figure 4). The specificity for the nucleotide’s
sugar moiety seemed not affected, however, since
deoxyadenosine triphosphate (dATP) was not incorpo-
rated when using an RNA template in the presence
of Mn2+. This discriminates the SARS-CoV RdRp
from, e.g. its PV equivalent, for which correct base
pairing was more important than the presence of a 20
hydroxyl group (40).
To establish the importance of pH, we tested SARS-
CoV RdRp activity in the pH range of 6.0–8.5. We
clearly observed an increase of nsp12 overall activity
with an optimum at pH 8.0 (Figure 3E), but differences
between pH 7.0 and 8.5 were marginal in terms of both
overall activity and amount of full-length product
produced (Figure 3F). Interestingly, pH 7.5 consistently
resulted in a significantly larger amount of initiation
product, suggesting that higher pH values stimulate the
processivity of the enzyme.
In additional assays, we tested the effect of monovalent
cations, bovine serum albumin and spermidine (data not
shown). No negative influence of potassium or sodium
ions was observed below a concentration of 50mM.
Neutral to slightly negative effects were found for
both BSA (tested for 0–0.1mg/ml), which is known to
stabilize enzymes and reduce potential side effects such
as absorbance to the plastic surface of the reaction tube
used. Finally, addition of spermidine, which binds to the
phosphate backbone of nucleic acids and is a known stim-
ulator of various polymerases, did not improve activity
in the tested concentration range up to 5mM.
RNA-binding properties of SARS-CoV nsp12
Our combined observations suggested that nsp12 is only
active in a primer-dependent fashion and may thus prefer
binding to double-stranded RNA (dsRNA). To determine
the affinity of nsp12 for dsRNA and ssRNA we performed
electrophoretic mobility shift assays, in which we titrated
purified nsp12 in the presence of 0.2 nM 50-32P-labeled
RNA (Figure 5). Subsequently, the percentage of bound
template and the Hill equation (see ‘Materials and
Methods’ section) were used to derive the enzyme’s disso-
ciation constants (Kd). For dsRNA the Kd was calculated
at 0.13±0.03 mM, whereas the Kd for ssRNA was
estimated to be 0.10±0.02mM.
Nsp12 nucleotide incorporation rates
For various viral RdRps, in vitro studies have defined bio-
chemical properties that could not be determined or were
largely obscured in in vivo assays. Furthermore, following
the basic characterization of individual enzymes, the inter-
play with templates, cofactors and other subunits of the
and 761, the latter two amino acids being part of the 
nidovirus-specific SDD motif (23,35–37). In other viral 
RdRps, single or multiple substitutions of the equivalent 
residues with alanine or asparagine were shown to change 
or even abolish polymerase activity (38,39), depending 
on the assay conditions used. For the PV 3Dpol, for 
example, it was found that mutagenesis of the motif C 
core sequence, changing it from GDD to GDN, was 
detrimental in the presence of Mg2+, but not when 
Mn2+ or Fe2+ were provided as divalent cation (38). To 
obtain an active site mutant that could be used as negative 
control during further development of our assays, we engi-
neered nsp12 mutant D618A. As portrayed in Figure 2B 
and C, the mutant protein displayed only 8 ±3% residual 
primer extension activity in our assays (Figure 2B–D), 
thus confirming the nsp12-specific nature of the RdRp 
activity described here and supporting the prior hypothe-
sis that this residue is a key player in the enzyme’s active 
site. Further or complete knockdown of activity may 
be obtained under slightly different assay conditions 
or in combination with substitution of other active site 
residues, which remain to be tested in future studies.
Biochemical determinants of the in vitro activity of the 
SARS-CoV nsp12
It is common practice to employ filter binding assays 
during optimization of polymerase activity assays. 
Although convenient and less time consuming than gel 
analysis of reaction products, these assays merely reveal 
incorporation of label, but do not provide direct informa-
tion on the length and integrity of the products. Therefore, 
when exploring the effects of different reaction buffer 
compositions, we consistently quantified and analyzed
[a-32P]ATP incorporation using denaturing 20%
acrylamide gels. The standard assay buffer consisted of 
20 mM Tris–HCl (pH 8.0), 10 mM KCl, 1 mM DTT, 
6 mM MgCl2, 5% glycerol, 0.1% Triton-X 100 and 
50 mM ATP.
First, the influence of reaction temperature on RdRp 
activity was tested within the range of 20–37C. Activity 
at 37C was 40% higher than at 30C, which is more 
commonly used in RdRp assays (Figure 3A) (37,40–42). 
However, a more detailed analysis revealed that this 
increase largely stemmed from enhanced initiation of 
primer extension rather than elongation, with the latter 
being decreased by 35% as judged from the amount of 
full-length product (primer + 10, Figure 3B). Therefore, 
all subsequent experiments were performed at 30C. 
Contrary to expectations however, the major extension 
product never matched the length of the primer plus 
10 nt, suggesting that nsp12 generally terminates before 
reaching the end of the primed poly(U) template. The 
results obtained with other templates are discussed 
subsequently.
It is well established that nucleic acid polymerases 
utilize divalent cations, mostly Mg2+, as cofactors to 
bind and coordinate the incoming nucleotide during the 
polymerization reaction (35,36). As shown in Figure 3C 
and D, the activity of nsp12 was positively correlated with 
the Mg2+ concentration and reached its optimum at
viral enzyme complex can be addressed. Ultimately, this
should facilitate the in vitro reconstitution of the holo-
enzyme complex and the analysis of its interactions at
each step of viral replication and transcription. After the
purification of active SARS-CoV nsp12 and exploration
of the reaction conditions, our subsequent step toward
such a future goal was to evaluate the rate of nucleotide
incorporation by the SARS-CoV RdRp. On a primed U10
template we found relatively poor incorporation rates
(1.2±0.4 nM/min) and a major product that was 2–3 nt
shorter than the expected full-length product (Figure 6A),
with product sizes displaying a similar Gaussian-like dis-
tribution as depicted in the graphs in Figure 3. On the
other hand, we also observed minor products that were
slightly longer than full length, suggesting slippage of the
polymerase at the end of the template. We did not detect
any terminal transferase activity on the templates used
(data not shown).
Figure 3. Biochemical determinants of SARS-CoV nsp12 activity. (A and B) Tests to determine the influence of temperature indicated that nsp12
incorporates ATP most efficiently at 37C, although this effect mainly stemmed from increased initiation. Based on these results, 30C was taken as
the standard for subsequent experiments. (C and D) Titration of the Mg2+ concentration showed that activity reaches its maximum at 6mM. (E and
F) The effect of pH on RdRp activity was evident as well, with lower pHs limiting the activity of the enzyme. All reactions were incubated for 60min
at 30C, unless otherwise indicated. Error bars in A, C and E represent standard error of the mean (n=3).
Previously, Cheng et al. (24) reported that their
unstable GST-nsp12 fusion protein had limited reverse
transcriptase activity. In contrast to these prior results,
our nsp12 was not able to efficiently use dATP to extend
an RNA primer (Figure 4A and B) and a similar result
was obtained with a DNA primer (data not shown).
To test whether nsp12 was able to incorporate [a-32P]
deoxyadenosine monophosphate (dAMP) when using
DNA templates, we employed a primed T10 template
similar to the RNA templates described above.
As shown in Figure 6B, nsp12 was capable of incorporat-
ing dAMP when incubated with a DNA template.
On average, a minor reduction (20%) in dAMP incor-
poration was observed in comparison to the activity on an
RNA template. The size distribution of products was
more different, and showed significantly less initiation
than on an RNA template (compare Figure 6A and B).
The incorporation rate of nsp12 increased dramatically
when we doubled the template length (VU20=27±3nM/
min, Figures 6C and 7), but we again observed a major
product that was 2 nt shorter than the expected full-length
product. When the primed poly(U) template was changed
to a primed heteromeric (CU)10, nsp12 activity increased
further (V(CU)10=45±2nM/min) and reached a level
comparable to that obtained for other viral RdRps on
similar short templates (40). When the products of the
latter reactions were resolved by denaturing PAGE
(Figure 6D) they were found to be longer than template
length. Similar products extending beyond unit length
have been often observed when short templates were
Figure 4. Nucleotide incorporation fidelity of nsp12. (A) Experimental
set-up of pulse-chase experiments with different nucleotides and a
primed poly(U) template (see Figure 2A). The reactions were initiated
with a limiting concentration of [a-32P]ATP to allow the incorporation
of a first nucleotide and the formation of a stable polymerase-template
complex. Subsequently, after 10min, different unlabeled nucleotides
were added to a final concentration of 50 mM to allow elongation
for another 30min. (B) SARS-CoV nsp12 allows only limited trans-
versional and transitional misincorporations. Interestingly, also in the
presence of dATP no significant activity was observed, implying that
the SARS-CoV RdRp is capable of discriminating between ATP and
dATP. (C) Pulse-chase experiments in the presence of 6mM Mn2+
show that manganese ions promote misincorporation of ribonucleotides
(both transversions and transitions). The selection against dATP
remained unaltered.
Figure 5. RNA binding affinity of nsp12. (A) A fixed concentration
(0.2 nM) of radiolabeled dsRNA or ssRNA (data not shown) was
titrated with purified nsp12 and the complexes formed were separated
from unbound RNA on a native 8% polyacrylamide gel. (B) Free and
bound RNA were quantified and fit to the Hill equation (see ‘Materials
and Methods’ section), resulting in Kd values of 0.13±0.3 mM for
dsRNA and 0.10±0.2 mM for ssRNA binding. R2 values of these
Hill fits were 0.97 and 0.98 for dsRNA and ssRNA, respectively.
Error bars represent standard error of the mean (n=3).
used for PV 3Dpol (43) and their generation can be
explained by various mechanisms, such as distributive
slippage, processive slippage, template switching or
terminal transferase activity (43 and references therein).
Future research is expected to address these mechanisms
in more detail.
DISCUSSION
Detailed kinetic and stoichiometric information plays an
important role in explaining the molecular basis of RdRp-
catalyzed ribonucleotide incorporation, the associated
mutation rate of viral genomes and, consequently, RNA
Figure 6. Analysis of nucleotide incorporation by nsp12. (A) Reactions with 0.1 mM nsp12, 1 mM template and 50 mM ATP were followed over time
and quenched with 50mM EDTA at the time points indicated. Gel analysis showed that, similar to the curves in Figure 3, the major accumulating
product is the primer (p) extended by 7 nt (i.e. p+7) and not the expected full-length product of n+10. (B) To assess whether nsp12 was capable of
DNA-templated incorporation of dATP, reactions were performed as in Figure 6A, but now using a DNA template. The time course illustrates
robust [a-32P]dAMP incorporation, implying that the SARS-CoV RdRp is able to utilize both RNA and DNA templates. The incorporation of
dAMP was 20% lower than that of AMP on an RNA template. (C) Time courses were additionally performed using an RNA template containing a
U20 template region. Similar to the shorter 10-nt template used in Figure 6A, the major product here was around 2 nt shorter than the expected full-
length product. (D) Changing the single-stranded template from U20 to a heteromeric (CU)10 not only increased the nucleotide incorporation rate by
34%, but also the behavior of nsp12 on the template. Products of the expected full-length size (p+20) were observed, but also products longer than
the template, hinting at, e.g. template switching by nsp12. Future research will address this observation in more detail. In this reaction both 50 mM
ATP and GTP were present. The gel image represents the top half of a 20% denaturing PAGE gel.
virus evolution. Furthermore, a comprehensive under-
standing of the differences between viral RdRps and
cellular polymerases is crucial in the design of specific
inhibitors of viral RNA synthesis and their subsequent
mechanistic characterization and optimization. Up till
now, all of the above information was particularly
limited, if not completely lacking, for the CoV RdRp,
due to enzyme insolubility, instability and low purification
yields.
This study reports the first successful expression and
purification of stable, soluble SARS-CoV nsp12, thus
paving the way for its further biochemical characteriza-
tion. Using a two-step procedure, the protein was purified
to near homogeneity, as confirmed by SDS–PAGE and
non-denaturing gel filtration. We found that even a
single-step purification scheme could produce an enzyme
preparation that combined specific activity with reason-
able purity (>80–85%). Of particular importance in our
expression protocol was the co-expression of the Ubp1
protease that mediated the in vivo removal of the
N-terminal Ub tag (Figure 1A) (26). Apparently, similar
to PV 3Dpol (30), SARS-CoV RdRp does not tolerate
additional amino acids at its N-terminus, likely because
they induce an unstable and largely inactive fold. Because
of the observed sensitivity to N-terminal fusions, it is
tempting to speculate that the processing of the pp1ab
cleavage generating the nsp12 N-terminus is of great
importance for proper folding and activity in vivo as
well. In line with this notion, it was reported that for the
related group 2 CoV mouse hepatitis virus (MHV) this
cleavage site indeed is indispensable for virus replication
(44). It still remains to be tested whether there is any effect
of the C-terminal His-tag on the activity of the enzyme
used in this study.
The SARS-CoV nsp12 is a relatively large protein
(932-amino-acid residues), e.g. much larger than the well
described RdRps of HCV (591 amino acids) and PV (461
amino acids), and may have, in addition to the C-terminal
RdRp domain, other functional or contributing domains
in its still uncharacterized N-terminal domain(s).
Previously, the PV and HCV RdRps were demonstrated
to bind RNA with Kd values of 2–10mM (45) and 3 mM
(46), respectively. Our data suggest that SARS-CoV nsp12
binds RNA with slightly higher affinity for both dsRNA
and ssRNA (Kd 0.1 mM). The relatively similar affinities
for dsRNA and ssRNA suggest that the lack of de novo
initiation may largely be due to a relatively open structure
and the absence of a conserved priming loop in the pre-
dicted thumb subdomain (23). The latter structural
element, a b-hairpin in, e.g. hepatitis C virus (HCV)
NS5B, is present in many known de novo initiating
RNA polymerases. Canonically, it functions by partly
obstructing the template binding cleft and is believed to
be essential for association with the single-stranded 30 end
of the template RNA (23,47,48).
Contrary to previous GST-pull downs performed for
nsp12 (49) and data obtained for other RdRps such as
the PV 3Dpol—which was reported to form multimers
and even lattices (45)—we were not able to establish
nsp12 multimerization using non-denaturing gel filtration.
Although this suggests that SARS-CoV RdRp exists
predominantly as monomer under the conditions used
here, it is likely that nsp12 binds to various other viral
replicase subunits (50) and cellular cofactors (51) in vivo.
The CoV holo-enzyme complex formed in this manner
may have more finely tuned characteristics than docu-
mented in this study. In addition, it remains to be tested
whether the C-terminal hexahistidine tag interferes with
multimerization. Clearly, these and other questions
should be addressed in more detail in future studies.
Upon binding to template and primer, we found nsp12
to have reproducible nucleotide incorporation rates on
the templates tested, but incorporation depended signi-
ficantly on the length of the template. Furthermore, on
heteromeric templates the SARS-CoV RdRp also per-
formed better and reached incorporation rates in the
same order (>nM/min) as the model polymerases from
PV and HCV, when correcting for enzyme and template
concentrations (40,52). In addition, the SARS-CoV nsp12
is also active on a DNA template, which may greatly
facilitate further investigations in view of the superior
stability of DNA templates and the fact that various
other SARS-CoV enzymes (17,33,53) have documented
affinity for DNA as well. It remains to be tested whether
SARS-CoV nsp12 is also active on a longer single-
stranded template, e.g. RNA templates based on the
terminal sequences of the viral genome, and whether it is
able to traverse the RNA secondary structures present in
such a molecule. Taken together, our data suggest that our
present purification scheme and assay constitute a
concrete starting point for further biochemical exploration
of the SARS-CoV RdRp and nsp12 targeted inhibitor
development.
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